PB
PharmaCyte Biotech, Inc. disclosed a 50% stake in QCLS
PharmaCyte Biotech, Inc. reported owning 50% of Q/C Technologies, Inc. (QCLS) (8,446,093 shares) in a Schedule 13D filed Nov 21, 2026.
A 13D means the holder may push for changes at the company.